MaxCyte Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for MaxCyte, Inc. (MXCT) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-41.06-37.92-23.57-19.08-11.82
Depreciation & Amortization4.794.572.701.421.05
Stock Based Compensation13.0813.9811.757.962.47
Change in Working Capital-0.753.82-3.98-1.64-0.86
Change in Accounts Receivable1.237.14-6.48-1.71-1.81
Change in Inventory1.36-4.53-3.49-1.41-0.89
Change in Accounts Payable-1.883.25-0.152.090.39
Change in Other Working Capital0.06-0.396.18-2.53-0.20
Other Operating Activities0.060.700.770.650.39
Net Cash from Operating Activities-27.61-21.69-14.78-10.68-8.78
Investing Activities
Capital Expenditures-1.65-3.70-18.48-3.83-2.07
Purchases of Investments-150.8658.68-6.35-191.18-14.51
Sales/Maturities of Investments159.44313.77284.6077.500.00
Net Cash from Investing Activities6.9354.98-24.82-195.01-16.58
Financing Activities
Debt Repayment0.000.000.00-4.990.00
Common Stock Issued2.062.142.89239.7128.97
Net Cash from Financing Activities2.062.142.89234.7228.90
Summary
Net Change in Cash-18.6235.44-36.7229.033.54
Cash at Beginning of Period46.5111.0747.7818.760.00
Cash at End of Period27.8846.5111.0747.780.00
Free Cash Flow-29.26-25.39-33.26-14.51-10.85
Supplemental Disclosures
Interest Paid0.000.000.000.420.42